Search

everythinglearnresearchcommunity

for

Search:↓

Bimatoprost eye drops make rabbit eyelashes longer, thicker, and darker, and increase the number of lashes without causing inflammation.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

The document concludes that specialized hair transplant techniques can be effective, with varying success rates depending on the donor area and patient factors.

The document concludes that individualized reconstruction plans are essential for improving function and appearance after head and neck burns.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.

A man with a rare disease experienced late hair whitening and loss, but hair color returned, suggesting a good outlook.

Male mice with FGF5 mutations grow longer hair than females.

There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

The study found that males with KFSD had severe skin and eye symptoms, while female carriers had milder symptoms.

Trichotillomania was successfully treated with risperidone and naltrexone.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Oral tofacitinib successfully treated total body hair loss in one patient.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Central lipohypertrophy in HIV-infected women may lead to shorter eyelashes.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.